KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for Neogenomics (NEO) over the last 13 years, with Q4 2025 value amounting to $89.9 million.

  • Neogenomics' Non-Current Deferred Tax Liability fell 1277.18% to $89.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $89.9 million, marking a year-over-year decrease of 1277.18%. This contributed to the annual value of $89.9 million for FY2025, which is 1277.18% down from last year.
  • Latest data reveals that Neogenomics reported Non-Current Deferred Tax Liability of $89.9 million as of Q4 2025, which was down 1277.18% from $20.8 million recorded in Q3 2025.
  • Neogenomics' Non-Current Deferred Tax Liability's 5-year high stood at $143.1 million during Q4 2021, with a 5-year trough of $1.7 million in Q1 2021.
  • For the 5-year period, Neogenomics' Non-Current Deferred Tax Liability averaged around $53.0 million, with its median value being $35.0 million (2022).
  • Per our database at Business Quant, Neogenomics' Non-Current Deferred Tax Liability crashed by 8935.09% in 2021 and then surged by 286496.56% in 2022.
  • Quarter analysis of 5 years shows Neogenomics' Non-Current Deferred Tax Liability stood at $143.1 million in 2021, then fell by 9.45% to $129.6 million in 2022, then fell by 8.63% to $118.4 million in 2023, then dropped by 12.89% to $103.1 million in 2024, then dropped by 12.77% to $89.9 million in 2025.
  • Its last three reported values are $89.9 million in Q4 2025, $20.8 million for Q3 2025, and $20.0 million during Q2 2025.